Background: Retrieval of <3 Sentinel lymph nodes (SLN) has been shown to be associated with decreased disease-specific survival. We aimed to find out if the real-world experience replicates the data. Methods: Overall, 529 patients with breast cancer who underwent SLN biopsy from January 2010 to December 2014 were retrospectively reviewed. Data were analyzed using SAS 9. 4 software. The chi-square test was used to see if body mass index (BMI) influences the number of SLN retrieved and to detect possible differences between using blue dye and radioisotopes for detecting SLN. Results: The proportion of retrieving 1, 2, and ≥3 SLNswas 21%, 35%, and 44%, respectively, with a median of 2 SLNs. There was no difference in the number of lymph nodes retrieved if the radioisotope was used alone or in combination with blue dye (P=0. 88). No change was noted in the median number of SLN retrieved in different quadrants of the breast. We obtained BMI in 454 patients. The rate of retrieving >2 SLNs in patients with normal BMI was 16%. This rate was 12% in overweight patients and 18% in thosewho were obese. We compared the SLN≤2 vs SLN>2 group, which were cross-tabbed against 3 BMI categories of normal, overweight, and obese. This was statistically significant, with a P-value of 0. 028. Conclusion: The real-world data suggest suboptimal retrieval of the number of median SLN compared to clinical trials. A higher BMI was associated with <3 SLN retrieved.